Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$637M |
| 2 |
Weyerhaeuser
WY
|
+$340M |
| 3 |
IQVIA
IQV
|
+$132M |
| 4 |
Halliburton
HAL
|
+$123M |
| 5 |
Dover
DOV
|
+$112M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.68B |
| 2 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$708M |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$460M |
| 4 |
RAI
Reynolds American Inc
RAI
|
+$293M |
| 5 |
Gilead Sciences
GILD
|
+$246M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 6.22% |
| 2 | Healthcare | 5.12% |
| 3 | Financials | 4.53% |
| 4 | Consumer Discretionary | 4.09% |
| 5 | Communication Services | 3.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TBHC
5226
DELISTED
The Brand House Collective
TBHC
| $54K | ﹤0.01% |
4,699
+2,921
| +164% | +$29.9K |
|
5227
PUT
LKQ Corp
LKQ
$5.91B
| $54K | ﹤0.01% |
1,500
-10,600
| -88% | -$361K |
|
5228
PUT
Norwegian Cruise Line
NCLH
$9.07B
| $54K | ﹤0.01% |
1,000
+800
| +400% | +$44.8K |
|
5229
Planet Fitness
PLNT
$4.45B
| $54K | ﹤0.01% |
2,006
-17,790
| -90% | -$432K |
|
5230
PRA Group
PRAA
$666M
| $54K | ﹤0.01% |
1,880
-11,449
| -86% | -$382K |
|
|
RDUS
5231
DELISTED
Radius Recycling
RDUS
| $54K | ﹤0.01% |
1,948
+1,094
| +128% | +$28.7K |
|
5232
S&T Bancorp
STBA
$1.85B
| $54K | ﹤0.01% |
1,359
-2,844
| -68% | -$105K |
|
|
VDTH
5233
DELISTED
Videocon d2h Limited
VDTH
| $54K | ﹤0.01% |
6,100
-3,000
| -33% | -$27.6K |
|
|
UBA
5234
DELISTED
Urstadt Biddle Properties Inc. Class A
UBA
| $54K | ﹤0.01% |
2,485
-1,048
| -30% | -$21.9K |
|
|
BHVN
5235
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $54K | ﹤0.01% |
1,442
+1,434
| +17,925% | +$43.5K |
|
5236
CALL
American Superconductor
AMSC
$1.5B
| $53K | ﹤0.01% |
11,700
+3,300
| +39% | +$12.8K |
|
5237
PUT
Apogee Enterprises
APOG
$876M
| $53K | ﹤0.01% |
1,100
+200
| +22% | +$9.83K |
|
|
ASRT
5238
PUT
DELISTED
Assertio
ASRT
| $53K | ﹤0.01% |
152
+10
| +7% | +$4.71K |
|
5239
Brookfield Infrastructure Partners
BIP
$18.4B
| $53K | ﹤0.01% |
2,051
+1,940
| +1,748% | +$48.7K |
|
5240
Cedar Fair
FUN
$1.8B
| $53K | ﹤0.01% |
817
+82
| +11% | +$5.5K |
|
5241
PennyMac Financial
PFSI
$3.97B
| $53K | ﹤0.01% |
2,978
-133
| -4% | -$2.29K |
|
5242
CALL
Telephone and Data Systems
TDS
$3.92B
| $53K | ﹤0.01% |
1,900
-35,500
| -95% | -$1M |
|
|
HZN
5243
DELISTED
Horizon Global Corporation
HZN
| $53K | ﹤0.01% |
3,016
+2,998
| +16,656% | +$48.8K |
|
|
VVUS
5244
DELISTED
Vivus Inc
VVUS
| $53K | ﹤0.01% |
5,339
-11,419
| -68% | -$121K |
|
5245
Barnes & Noble Education
BNED
$447M
| $52K | ﹤0.01% |
79
-99
| -56% | -$70K |
|
5246
PUT
Geron
GERN
$821M
| $52K | ﹤0.01% |
23,800
-8,000
| -25% | -$18.9K |
|
5247
Ocular Therapeutix
OCUL
$1.84B
| $52K | ﹤0.01% |
8,520
+7,713
| +956% | +$49.7K |
|
5248
SPX Corp
SPXC
$10.7B
| $52K | ﹤0.01% |
1,756
-10,174
| -85% | -$267K |
|
5249
CALL
UGI
UGI
$7.78B
| $52K | ﹤0.01% |
1,100
+700
| +175% | +$34.2K |
|
|
SRNE
5250
DELISTED
Sorrento Therapeutics, Inc.
SRNE
| $52K | ﹤0.01% |
30,700
+3,700
| +14% | +$6.79K |
|
Similar funds
Barclays's Q3 2017 Portfolio in Review
As of Q3 2017, Barclays held 7,380 positions worth $97.1B, up 4% from $93.4B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
Barclays's Q3 2017 filing shows 424 new, 3,249 increased, 2,816 reduced and 405 closed positions. Its largest new stake was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M. The largest sale was Invesco QQQ Trust, an estimated $3.68B.
By sector, the portfolio is most concentrated in Technology at 6.2% of assets, up from 6.1% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2017 buy was Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A: 39,656 shares worth $42.4M.
- Barclays added most to State Street SPDR S&P 500 ETF Trust in Q3 2017, an estimated $637M increase.
- Barclays's biggest Q3 2017 reduction was Invesco QQQ Trust, cutting an estimated $3.68B.
- Barclays fully exited Reynolds American Inc in Q3 2017, selling an estimated $293M.
- Barclays's ten largest holdings make up 29% of its $97.1B portfolio in Q3 2017.
- Barclays opened 424 new positions and closed 405 in Q3 2017.
- Barclays's portfolio value rose 4% quarter-over-quarter to $97.1B.
Based on Barclays's 13F filing for Q3 2017, filed 14 Nov 2017.